|
|
???tair.name??? >
???browser.page.title.author???
|
"mataraza j"???jsp.browse.items-by-author.description???
Showing items 1-4 of 4 (1 Page(s) Totally)
1
View [10|25|50] records per page
| 臺大學術典藏 |
2022-09-15T01:08:59Z |
A first-in-human phase 1 dose escalation study of spartalizumab (PDR001), an anti-PD-1 antibody, in patients with advanced solid tumors
|
Naing A.; Gainor J.F.; Gelderblom H.; Forde P.M.; Butler M.O.; Chia-Chi Lin; Sharma S.; Ochoa De Olza M.; Varga A.; Taylor M.; Schellens J.H.M.; Wu H.; Sun H.; Silva A.P.; Faris J.; Mataraza J.; Cameron S.; Bauer T.M. |
| 國立成功大學 |
2021 |
Phase II, Randomized Study of Spartalizumab (PDR001), an Anti-PD-1 Antibody, versus Chemotherapy in Patients with Recurrent/Metastatic Nasopharyngeal Cancer
|
Even, C.;Wang, H.-M.;Li, S.-H.;Ngan, R.K.-C.;Dechaphunkul, A.;Zhang, L.;Yen, C.-J.;Chan, P.C.;Chakrabandhu, S.;Ma, B.B.Y.;Tanasanvimon, S.;Lee, V.H.F.;Lou, P.-J.;Li, Z.;Spira, A.I.;Sukari, A.;Guigay, J.;McCune, S.;Gonzalez-Maffe, J.;Szpakowski, Szpakowski S.;Yao, Yao Y.;Liang, H.;Mataraza, J.;Sechaud, R.;Manenti, L.;Lim, D.W.-T. |
| 臺大學術典藏 |
2020-05-25T07:35:09Z |
Phase I/II study of spartalizumab (PDR001), an anti-PD1 mAb, in patients with advanced melanoma or non-small cell lung cancer
|
Chia-Chi Lin; Taylor M; Boni V; Brunsvig P.F; Geater S.L; Salvagni S; Garrido Lopez P; ?zg?ro?lu M; Sriuranpong V; Ponce Aix S; Ascierto P.A; Fasolo A; Sezer A; Kowalski D.M; Faris J.E; Cameron S; Mataraza J; Wu H; Antona V; Ochoa de Olza M. |
| 臺大學術典藏 |
2020-05-25T07:35:01Z |
A first-in-human phase 1 dose escalation study of spartalizumab (PDR001), an anti-PD-1 antibody, in patients with advanced solid tumors
|
Naing A; Gainor J.F; Gelderblom H; Forde P.M; Butler M.O; Chia-Chi Lin; Sharma S; Ochoa De Olza M; Varga A; Taylor M; Schellens J.H.M; Wu H; Sun H; Silva A.P; Faris J; Mataraza J; Cameron S; Bauer T.M. |
Showing items 1-4 of 4 (1 Page(s) Totally)
1
View [10|25|50] records per page
|
